Long-Awaited, Global Trial of Fetal Cells for Parkinson's

Fox, Cynthia
July 2014
Bioscience Technology;7/21/2014, p1
Trade Publication
The article discusses the global trial of the fetal cell transplant for Parkinson's diseases (PD) patients and embryonic stem (ES) cell PD therapies highlighted at the 2014 International Society for Stem Cell Research (ISSCR) meeting. Topics discussed include an outline of the fetal cell TRANSEURO PD trial by researcher Roger Barker and sponsored by the European Union and neurologist Lorenz Studer's description of how his team created human dopamine neurons that survived long-term.


Related Articles

  • Long-term clinical outcomes after fetal cell transplantation in parkinson disease: implications for the future of cell therapy. Bega, Danny; Krainc, Dimitri // JAMA: Journal of the American Medical Association;2/12/2014, Vol. 311 Issue 6, p617 

    IMPORTANCE: Recent advances in stem cell technologies have rekindled an interest in the use of cell replacement strategies for patients with Parkinson disease. This study reports the very long-term clinical outcomes of fetal cell transplantation in 2 patients with Parkinson disease. Such...

  • Stem Cells Able to Form Optic Cup.  // Review of Ophthalmology;Jul2012, Vol. 19 Issue 7, p6 

    The article discusses the study by Yoshiki Sasai on the use human-derived stem cell or human embryonic stem cells (hESCs), which is able to form an optic cup.

  • Stem cells: the good, bad and barely in control. Carson, Christian T.; Aigner, Stefan; Gage, Fred H. // Nature Medicine;Nov2006, Vol. 12 Issue 11, p1237 

    The article reports on an important finding during the generation of dopaminergic neurons from stem cells. Robust differentiation of human embryonic stem cells (HESCs) into dopaminergic neurons was achieved by coculturing HESC-derived neural precursors with immortalized human fetal midbrain...

  • Autologous stem cell transplantation improved follicular lymphoma outcomes.  // Hem/Onc Today;5/25/2013, Vol. 14 Issue 10, p28 

    The article discusses the findings of a retrospective, multicenter study which revealed the association of autologous stem cell transplantation with better survival outcomes compared to rituximab-containing regimes in a cohort of patients with follicular lymphoma.

  • Issues in genetic association studies: limitations of statistical analysis and biological plausibility. Van der Velden, W. J. F. M.; Feuth, T.; Stevens, W. B. C.; Donnelly, J. P.; Blijlevens, N. M. A. // Bone Marrow Transplantation;Jun2011, Vol. 46 Issue 6, p906 

    A letter to the editor is presented in response to the article "Prognostic significance of genetic variants in the IL-23/Th17 pathway for the outcome of T cell-depleted allogeneic stem cell transplantation," by A Carvalho and colleagues.

  • Stem cell transplantation in children associated with less time to prepare for end-of-life. Cona, Christen; Harris, Jason; Lawrence, Leah; Levitan, David; Southall, Jennifer // Hem/Onc Today;6/25/2010, Vol. 11 Issue 12, p47 

    The article discusses research study on children who died after stem cell transplantation, by C. K. Ullrich and colleagues, published in the 2010 issue of "Blood."

  • New strategies needed for use of allogeneic stem cell transplantation in treatment of multiple myeloma. Cona, Christen; Harris, Jason; Southall, Jennifer // Hem/Onc Today;9/25/2010, Vol. 11 Issue 18, p27 

    The article focuses on the study of the International Myeloma Working Group suggesting the need for new strategies to improve the safety and efficacy of allogeneic stem cell transplantation for patients with multiple myeloma.

  • Better CMV medications urged for haploidentical stem cell transplant patients.  // Infectious Disease News;Nov2013, Vol. 26 Issue 11, p40 

    The article discusses research being done on the use of prophylaxis in patients before haploidentical stem cell transplantation, which references a study by E. Shmueli published in a 2013 issue of the "Journal of Infectious Diseases."

  • Cell therapy: Stem cells wrap neurons.  // Nature;10/18/2012, Vol. 490 Issue 7420, p312 

    The article discusses the study by David Rowitch and colleagues of the University of California, San Francisco, which transplanted stem cells into four young boys with genetic disease and found that it engrafted and myelinated brain cells.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics